Table 3 Long-term follow up results
From: Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers
Recurrence | Group A n (%) | Group B n (%) | Group C n (%) | P value |
|---|---|---|---|---|
Local Recurrence | 15 (21.7) | 5 (8.6) | 18 (34) | 0.012 |
Median(range) disease free(months) | 53.3(0.57-176) | 33.78(6.8-139) | 41.5(4.7-136) | NS |
Systemic recurrence | 14 (20.3) | 13(22.4) | 18(33.9) | NS (0.543) |
5 year cancer-specific survival rate | (49.3) | (69.9) | (38.8) | 0. 14 |